annual EBIT:
-$343.89M-$101.72M(-42.01%)Summary
- As of today (June 1, 2025), DYN annual earnings before interest & taxes is -$343.89 million, with the most recent change of -$101.72 million (-42.01%) on December 31, 2024.
- During the last 3 years, DYN annual EBIT has fallen by -$193.86 million (-129.22%).
- DYN annual EBIT is now -7047.91% below its all-time high of -$4.81 million, reached on December 31, 2018.
Performance
DYN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$122.37M-$25.26M(-26.02%)Summary
- As of today (June 1, 2025), DYN quarterly earnings before interest & taxes is -$122.37 million, with the most recent change of -$25.26 million (-26.02%) on March 31, 2025.
- Over the past year, DYN quarterly EBIT has dropped by -$53.22 million (-76.95%).
- DYN quarterly EBIT is now -2164.89% below its all-time high of -$5.40 million, reached on December 31, 2019.
Performance
DYN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$397.10M-$53.22M(-15.47%)Summary
- As of today (June 1, 2025), DYN TTM earnings before interest & taxes is -$397.10 million, with the most recent change of -$53.22 million (-15.47%) on March 31, 2025.
- Over the past year, DYN TTM EBIT has dropped by -$131.25 million (-49.37%).
- DYN TTM EBIT is now -6663.77% below its all-time high of -$5.87 million, reached on September 30, 2019.
Performance
DYN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
DYN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.0% | -77.0% | -49.4% |
| 3 y3 years | -129.2% | -242.0% | -147.2% |
| 5 y5 years | -2214.3% | -1463.1% | -1978.7% |
DYN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -129.2% | at low | -242.0% | at low | -147.2% | at low |
| 5 y | 5-year | -2214.3% | at low | -1463.1% | at low | -1978.7% | at low |
| alltime | all time | -7047.9% | at low | -2164.9% | at low | -6663.8% | at low |
DYN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$122.37M(+26.0%) | -$397.10M(+15.5%) |
| Dec 2024 | -$343.89M(+42.0%) | -$97.11M(-8.1%) | -$343.89M(+9.4%) |
| Sep 2024 | - | -$105.66M(+46.8%) | -$314.47M(+16.0%) |
| Jun 2024 | - | -$71.96M(+4.1%) | -$271.08M(+2.0%) |
| Mar 2024 | - | -$69.16M(+2.2%) | -$265.85M(+9.8%) |
| Dec 2023 | -$242.16M(+41.6%) | -$67.69M(+8.7%) | -$242.16M(+12.8%) |
| Sep 2023 | - | -$62.27M(-6.7%) | -$214.62M(+10.3%) |
| Jun 2023 | - | -$66.74M(+46.8%) | -$194.62M(+7.7%) |
| Mar 2023 | - | -$45.46M(+13.2%) | -$180.64M(+5.7%) |
| Dec 2022 | -$170.96M | -$40.15M(-5.0%) | -$170.96M(-6.5%) |
| Sep 2022 | - | -$42.28M(-19.9%) | -$182.78M(-0.3%) |
| Jun 2022 | - | -$52.76M(+47.4%) | -$183.26M(+14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$35.78M(-31.1%) | -$160.67M(+7.1%) |
| Dec 2021 | -$150.03M(+154.1%) | -$51.96M(+21.5%) | -$150.03M(+18.5%) |
| Sep 2021 | - | -$42.77M(+41.8%) | -$126.63M(+29.7%) |
| Jun 2021 | - | -$30.16M(+20.0%) | -$97.66M(+27.9%) |
| Mar 2021 | - | -$25.13M(-12.0%) | -$76.35M(+29.3%) |
| Dec 2020 | -$59.04M(+297.3%) | -$28.57M(+107.2%) | -$59.04M(+64.6%) |
| Sep 2020 | - | -$13.79M(+55.7%) | -$35.88M(+28.3%) |
| Jun 2020 | - | -$8.86M(+13.1%) | -$27.96M(+46.4%) |
| Mar 2020 | - | -$7.83M(+44.9%) | -$19.10M(+69.4%) |
| Dec 2019 | -$14.86M(+208.9%) | -$5.40M(-8.0%) | -$11.27M(+92.0%) |
| Sep 2019 | - | -$5.87M | -$5.87M |
| Dec 2018 | -$4.81M | - | - |
FAQ
- What is Dyne Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics annual EBIT year-on-year change?
- What is Dyne Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly EBIT year-on-year change?
- What is Dyne Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics TTM EBIT year-on-year change?
What is Dyne Therapeutics annual earnings before interest & taxes?
The current annual EBIT of DYN is -$343.89M
What is the all time high annual EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high annual earnings before interest & taxes is -$4.81M
What is Dyne Therapeutics annual EBIT year-on-year change?
Over the past year, DYN annual earnings before interest & taxes has changed by -$101.72M (-42.01%)
What is Dyne Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of DYN is -$122.37M
What is the all time high quarterly EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly earnings before interest & taxes is -$5.40M
What is Dyne Therapeutics quarterly EBIT year-on-year change?
Over the past year, DYN quarterly earnings before interest & taxes has changed by -$53.22M (-76.95%)
What is Dyne Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of DYN is -$397.10M
What is the all time high TTM EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM earnings before interest & taxes is -$5.87M
What is Dyne Therapeutics TTM EBIT year-on-year change?
Over the past year, DYN TTM earnings before interest & taxes has changed by -$131.25M (-49.37%)